HTG MOLECULAR DIAGNOSTICS, INC Quarterly Nonoperating Income (Expense) in USD from Q3 2014 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Htg Molecular Diagnostics, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2014 to Q1 2023.
  • Htg Molecular Diagnostics, Inc Nonoperating Income (Expense) for the quarter ending March 31, 2023 was -$40K, a 83.6% increase year-over-year.
  • Htg Molecular Diagnostics, Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was -$551K, a 176% decline year-over-year.
  • Htg Molecular Diagnostics, Inc annual Nonoperating Income (Expense) for 2022 was -$754K, a 208% decline from 2021.
  • Htg Molecular Diagnostics, Inc annual Nonoperating Income (Expense) for 2021 was $701K.
  • Htg Molecular Diagnostics, Inc annual Nonoperating Income (Expense) for 2020 was -$1.27M, a 280% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$551K -$40K +$203K +83.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$754K -$138K +$122K +46.9% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 -$876K -$167K +$91.6K +35.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$968K -$206K -$1.69M -114% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $722K -$243K +$21K +7.97% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $701K -$260K +$5.33K +2.01% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $696K -$258K -$19.5K -8.18% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $715K $1.48M +$2.19M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$1.47M -$264K -$203K -332% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$1.27M -$265K -$191K -255% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$1.08M -$239K -$116K -94% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$964K -$705K -$621K -739% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$343K -$61.2K -$8.64K -16.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$334K -$74.6K -$12.2K -19.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$322K -$123K -$84.3K -218% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$238K -$84K -$48.5K -136% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$189K -$52.5K +$102K +66% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$291K -$62.5K +$175K +73.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 -$467K -$38.7K +$239K +86.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$706K -$35.5K +$297K +89.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 -$1M -$154K +$232K +60% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$1.23M -$238K +$184K +43.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$1.42M -$278K +$152K +35.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$1.57M -$332K +$157K +32.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$1.73M -$386K -$29.4K -8.22% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$1.7M -$422K -$75.9K -21.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-23
Q3 2016 -$1.62M -$430K -$97K -29.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$1.53M -$489K +$1.24M +71.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$2.76M -$357K -$267K -295% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$2.5M -$346K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-23
Q3 2015 -$333K -$163K -95.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$1.73M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$90.3K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 -$170K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.